التفاصيل البيبلوغرافية
| العنوان: |
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: Possible role of endocannabinoids |
| المؤلفون: |
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G.G., Svensen, H., Stoknes, I., Sjövall, P., Magnusson, Y., Balvers, M.G.J., Verhoeckx, K.C.M., Tvrzicka, E., Bryhn, M., Kopecky, J. |
| المصدر: |
PLoS ONE, 6, 7 |
| سنة النشر: |
2012 |
| المجموعة: |
TU Delft: Institutional Repository (Delft University of Technology) |
| مصطلحات موضوعية: |
Research, Healthy for Life, Healthy Living, Life, QS - Quality & Safety, EELS - Earth, Environmental and Life Sciences |
| الوصف: |
Background: n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity-associated disorders. We hypothesised that the latter effect will be more pronounced when DHA/EPA is supplemented as phospholipids rather than as triglycerides. Methodology/Principal Findings: In a 'prevention study', C57BL/6J mice were fed for 9 weeks on either a corn oil-based high-fat obesogenic diet (cHF; lipids ~35% wt/wt), or cHF-based diets in which corn oil was partially replaced by DHA/EPA, admixed either as phospholipids or triglycerides from marine fish. The reversal of obesity was studied in mice subjected to the preceding cHF-feeding for 4 months. DHA/EPA administered as phospholipids prevented glucose intolerance and tended to reduce obesity better than triglycerides. Lipemia and hepatosteatosis were suppressed more in response to dietary phospholipids, in correlation with better bioavailability of DHA and EPA, and a higher DHA accumulation in the liver, white adipose tissue (WAT), and muscle phospholipids. In dietary obese mice, both DHA/EPA concentrates prevented a further weight gain, reduced plasma lipid levels to a similar extent, and tended to improve glucose tolerance. Importantly, only the phospholipid form reduced plasma insulin and adipocyte hypertrophy, while being more effective in reducing hepatic steatosis and low-grade inflammation of WAT. These beneficial effects were correlated with changes of endocannabinoid metabolome in WAT, where phospholipids reduced 2-arachidonoylglycerol, and were more effective in increasing anti-inflammatory lipids such as N-docosahexaenoylethanolamine. Conclusions/Significance: Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT. © 2012 Rossmeisl et al. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| العلاقة: |
uuid:9d2982c9-797d-40a5-bf99-6084fe77170c; 461064; http://resolver.tudelft.nl/uuid:9d2982c9-797d-40a5-bf99-6084fe77170cTest |
| الإتاحة: |
http://resolver.tudelft.nl/uuid:9d2982c9-797d-40a5-bf99-6084fe77170cTest |
| رقم الانضمام: |
edsbas.A90D0927 |
| قاعدة البيانات: |
BASE |
